In The News,

Louis Jacques Discusses New Drug Approvals and Reimbursement with Pink Sheet

September 15, 2022, ADVI’s Louis Jacques, chief clinical officer, sat down with the Pink Sheet to discuss how FDA and CMS are working to ensure a smooth handoff from new drug approval to reimbursement. Read the full article here.